Search results
View Dave Dobkin’s profile on LinkedIn, a professional community of 1 billion members. Global Strategy and Investment Executive with substantial international experience in…
- 500+
- LifeSci Capital, LLC
- Harvard-Westlake
- New York, NY
Oct 14, 2020 · CFO and Director David Dobkin is currently a Managing Director at LifeSci Capital. The SPAC plans to target the biopharma, medical technology, digital health, and healthcare services...
- Renaissance Capital
Oct 14, 2020 · The company is led by CEO and Chairman Andrew McDonald and COO and Director Michael Rice, who are Founding Partners at healthcare-dedicated investment bank LifeSci Capital. CFO and Director David Dobkin is currently a Managing Director at LifeSci Capital.
Dec 5, 2022 · The LifeSci-affiliated, LifeSci Acquisition II Corp., 2 for which David Dobkin served as CFO, merged with Science 37 and its stock price has dropped from the merger closing price of $9.01...
- Diffusion Pharmaceuticals Inc.
Nov 20, 2020 · CFO and Director David Dobkin is currently a Managing Director at LifeSci Capital. The SPAC plans to target the biopharma, medical technology, digital health, and healthcare services sectors in...
- Renaissance Capital
David Dobkin LifeSci Acquisition II Corp – CFO. I’d like to provide you with a quick overview on the transaction.
Nov 20, 2020 · CFO and Director David Dobkin is currently a Managing Director at LifeSci Capital. The SPAC plans to target the biopharma, medical technology, digital health, and healthcare services sectors in North America or Europe.
